08.07.2024 13:58:26 - dpa-AFX: *REGENERON ANTICIPATES $24 MLN R&D CHARGE IN Q2 RESULTS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Regeneron Pharmaceuticals 881535 NASDAQ 1.108,810 08.08.24 21:47:20 +41,010 +3,84% 1.108,700 1.109,410 1.074,620 1.067,800

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH